CellCentric (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- May 19, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Founders
- Will West
- Company Description
- CellCentric is a biotechnology company that develops p300/CBP inhibitors to treat cancer and multiple myeloma.
- Market
- Cancer treatment
- Location
- Cambridge, UK
- Coinvestors
- RA Capital Management, Forbion, Avego Bioscience Capital, BrightEdge